Home/Filings/4/0000899243-21-005020
4//SEC Filing

Farrell Edward 4

Accession 0000899243-21-005020

CIK 0001596946other

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 4:20 PM ET

Size

21.7 KB

Accession

0000899243-21-005020

Insider Transaction Report

Form 4
Period: 2021-02-03
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2021-02-03+96,000125,757 total
  • Sale

    Ordinary Shares

    2021-02-03$5.07/sh96,000$487,05629,757 total
  • Exercise/Conversion

    Options to acquire ordinary shares

    2021-02-0396,0000 total
    Exp: 2023-04-10Ordinary Shares (96,000 underlying)
Holdings
  • Employee Stock Option (right to buy)

    Exercise: $8.00Exp: 2024-04-29Ordinary Shares (79,000 underlying)
    79,000
  • Restricted Stock Units

    Ordinary Shares (12,257 underlying)
    12,257
  • Restricted Stock Units

    Ordinary Shares (1,488 underlying)
    1,488
  • Employee Stock Option (right to buy)

    Exercise: $11.92Exp: 2026-05-31Ordinary Shares (30,000 underlying)
    30,000
  • Employee Stock Option (right to buy)

    Exercise: $15.17Exp: 2025-05-19Ordinary Shares (30,000 underlying)
    30,000
  • Employee Stock Option (right to buy)

    Exercise: $7.58Exp: 2027-05-23Ordinary Shares (40,000 underlying)
    40,000
  • Restricted Stock Units

    Ordinary Shares (30,000 underlying)
    30,000
  • Restricted Stock Units

    Ordinary Shares (55,000 underlying)
    55,000
  • Ordinary Share Option (Right to Buy)

    Exercise: $4.72Exp: 2030-10-31Ordinary Shares (20,000 underlying)
    20,000
Footnotes (13)
  • [F1]Restricted Stock Units convert into ordinary shares on a one-for-one basis.
  • [F10]On January 7, 2020, the Reporting Person was granted 2,232 Restricted Stock Units, of which 744 have vested and have been exercised. The remaining 1,488 Restricted Stock Units will vest in two equal installments on January 7, 2022 and January 7, 2023.
  • [F11]On May 24, 2020, the Reporting Person was granted 55,000 Restricted Stock Units, vesting in three equal annual installments beginning May 24, 2021.
  • [F12]The option vests and becomes exercisable in three equal annual installments beginning October 31, 2021.
  • [F13]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.19, inclusive. The Reporting Person undertakes to provide to Quotient Limited and any security holder of Quotient Limited, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (13) to this Form 4.
  • [F2]All 30,000 options have vested and remain exercisable.
  • [F3]All 30,000 options have vested and remain exercisable.
  • [F4]The exercise price was paid in pounds sterling, at GBP0.003 per share.
  • [F5]All 96,000 options have vested and have been exercised.
  • [F6]All 79,000 options have vested and remain exercisable.
  • [F7]All 40,000 options have vested and remain exercisable.
  • [F8]On May 24, 2018, the Reporting Person was granted 36,773 Restricted Stock Units, of which 24,516 have vested and have been exercised. The remaining 12,257 Restricted Stock Units will vest on May 24, 2021.
  • [F9]On May 24, 2019, the Reporting Person was granted 45,000 Restricted Stock Units, of which 15,000 have vested and have been exercised. The remaining 30,000 Restricted Stock Units will vest in two equal installments on May 24, 2021 and May 24, 2022.

Issuer

Quotient Ltd

CIK 0001596946

Entity typeother

Related Parties

1
  • filerCIK 0001604629

Filing Metadata

Form type
4
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 4:20 PM ET
Size
21.7 KB